Christie & Co publish key market insights

Christie Group PLC
18 October 2023
 

18 October 2023

 

Christie Group plc

("Christie Group" or the "Company")

 

Christie & Co publish key insights into the Care, Pharmacy & Dental markets

 

Christie Group plc (CTG.L) is pleased to report that its agency and advisory business, Christie & Co, has published its 2023 Market Review Reports for three of its key sectors in Care, Pharmacy and Dentistry.

 

The Pharmacy Market Review 2023 analyses a range of topics relating to the UK pharmacy business market, including market composition, employment challenges, dispensing and services activity, online pharmacy, and the finance landscape. The full Pharmacy Market Review 2023 report is available to read at: https://www.christie.com/pharmacy-market-review-2023/

 

The Care Market Review 2023 focuses on a range of issues relating to the UK healthcare business market, including healthcare capital markets, land and development, the transactional market, operational costs, shifts in local authority fee rates, operator sentiment, the German healthcare market, and the finance and insurance landscapes. The full Care Market Review 2023 report is available to read at: https://www.christie.com/care-market-review-2023/

 

The Dental Market Review 2023 offers a panoramic view of the UK dental business sector, spotlighting important areas, including sector ownership structures, evolving market dynamics, current pricing patterns, an insightful operational review, and an assessment of the current appetite of banks to lend to the sector. The full Dental Market Review 2023 report is available to read at: https://www.christie.com/dental-market-review-2023/

 

Commenting on the publications, Dan Prickett, Group Chief Executive said: "Christie & Co's sector-specialist knowledge is highly valued by its clients and is the common theme that runs through everything they do whether that be in brokerage, valuation or advisory activities. These three publications provide the very latest view on those sectors following an eventful 2023 for the UK economy."

 

Enquiries:

 

Christie Group plc


Daniel Prickett

Chief Executive

07885 813 101



Tony Evans
Head of Pharmacy, Christie & Co

 

Richard Lunn
Christie & Co, Managing Director - Care

 

Paul Graham

Head of Dental, Christie & Co

07721 884 386


07768 646 989


07739 876 621



Shore Capital

Patrick Castle / Iain Sexton

Nominated Advisor and Broker


020 7408 4090

 


Notes to Editors:

Christie Group plc, quoted on AIM, is a leading professional business services group with 38 offices across the UK and Europe, catering to its specialist markets in the hospitality, leisure, healthcare, medical, childcare & education and retail sectors.

 

Christie Group operates in two complementary business divisions: Professional & Financial Services (PFS) and Stock & Inventory Systems & Services (SISS). These divisions trade under the brand names: PFS - Christie & Co, Pinders, Christie Finance and Christie Insurance: SISS - Orridge, Venners and Vennersys.

 

Tracing its origins back to 1846, the Group has a long-established reputation for offering valued services to client companies in agency, valuation services, investment, consultancy, project management, multi-functional trading systems and online ticketing services, stock audit and inventory management. The diversity of these services provides a natural balance to the Group's core agency business.

 

For more information, please go to www.christiegroup.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings